NLM Logo

Leuvectin MeSH Supplementary Concept Data 2024


MeSH Supplementary
Leuvectin
Unique ID
C494381
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C494381
Registry Number
0
Heading Mapped to
*Cancer Vaccines
Frequency
1
Note
Leuvectin (Vical Inc., San Diego, CA) is a gene transfer product in which a plasmid encoding the human interleukin-2 (IL-2) gene is complexed with the cationic lipid 1,2-dimyristyloxypropyl-3-dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine (DMRIE/DOPE); vaccination in patients with metastatic renal cell carcinoma is claimed to be safe & well tolerated
Source
Cancer 2004 Dec 1;101(11):2557-66
Indexing Information
Gene Transfer Techniques
Date of Entry
2004/12/23
Revision Date
2004/12/23
Leuvectin Preferred
page delivered in 0.002s